Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2728]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
Changing the standard treatment for lymphoma with bendamustine
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Changing the standard treatment for lymphoma with bendamustine ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Continuing bevacizumab with second-line chemotherapy for colorectal cancer
Dr Dirk Arnold - University Cancer Center Hamburg, Germany
Continuing bevacizumab with second-line chemotherapy for colorectal cancer ( Dr Dirk Arnold - University Cancer Center Hamburg, Germany )
3 Jun 2012
Combined chemo-radiation extends survival in patients with anaplastic...
Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam...
Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )
3 Jun 2012
Bendamustine regimen more effective for lymphoma than standard CHOP
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Current treatment practices in metastatic castration resistant prostate cancer
Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo...
Current treatment practices in metastatic castration resistant prostate cancer ( Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo Berruti )
22 May 2012
Targeting DNA damage response and repair excluding PARP for triple negative...
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012
Molecular characterisation of breast cancer: the mutational landscape
Prof Sam Aparicio - University of British Columbia, Vancouver, Canada
Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )
17 May 2012
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer
Prof Richard Finn - Universtity of California, Los Angeles, USA
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )
17 May 2012
Prognostic significance of progesterone receptor-positive tumour cells within...
Dr Aleix Prat - University of North Carolina, USA
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer ( Dr Aleix Prat - University of North Carolina, USA )
17 May 2012
Oncology nurses should take the lead
Birgitte Grube - President of EONS
Oncology nurses should take the lead ( Birgitte Grube - President of EONS )
10 May 2012
Impact and management of malignant wounds
Dr Betina Lund-Nielsen - University of Copenhagen, Denmark
Impact and management of malignant wounds ( Dr Betina Lund-Nielsen - University of Copenhagen, Denmark )
10 May 2012
Effects of metformin in pancreatic cancer with diabetes
Prof Donghui Li - University of Texas MD Anderson Cancer Center, Houston, USA
Effects of metformin in pancreatic cancer with diabetes ( Prof Donghui Li - University of Texas MD Anderson Cancer Center, Houston, USA )
16 Apr 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation